Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Erez_Israeli
|
| gptkbp:country |
gptkb:India
|
| gptkbp:foundedBy |
gptkb:Kallam_Anji_Reddy
|
| gptkbp:foundedYear |
1984
|
| gptkbp:headquartersLocation |
gptkb:Hyderabad
|
| https://www.w3.org/2000/01/rdf-schema#label |
DRREDDY
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:ISIN |
INE089A01023
|
| gptkbp:listedOn |
gptkb:Forbes_Global_2000
|
| gptkbp:logo |
Dr._Reddy's_Laboratories_logo.svg
|
| gptkbp:numberOfEmployees |
~24,000
|
| gptkbp:officialName |
Dr. Reddy's Laboratories Limited
|
| gptkbp:products |
Over-the-counter drugs
Active pharmaceutical ingredients Generic drugs |
| gptkbp:revenue |
₹24,500 crore (2023)
|
| gptkbp:servesArea |
Worldwide
|
| gptkbp:stockExchange |
gptkb:NYSE
gptkb:NSE BSE |
| gptkbp:stockSymbol |
gptkb:DRREDDY
|
| gptkbp:subsidiary |
Dr. Reddy's Laboratories Inc.
|
| gptkbp:website |
https://www.drreddys.com/
|
| gptkbp:bfsParent |
gptkb:Dr._Reddy's_Laboratories
|
| gptkbp:bfsLayer |
6
|